Rapidly rising lactate with peritoneal signs requires emergency surgery
Not specific alone but supports clinical decision
LDH
LDH >350 U/L is a severity marker
Reflects tissue necrosis
Correlates with adverse outcomes
Serial measurement trend
Rising LDH with worsening pain suggests progression
Decreasing LDH with treatment suggests improvement
Inflammatory markers
CRP
Elevated in moderate to severe disease
May help triage severity
Procalcitonin
Elevated with bacterial translocation and sepsis
Guides antibiotic decision in uncertain cases
D-dimer
May predict severity in some studies
Elevated in mesenteric venous thrombosis
Infection and coagulation labs
Stool studies
Stool culture for bacterial pathogens
Salmonella, Shigella, Campylobacter, E. coli O157:H7
CMV stool PCR in immunocompromised
C. difficile toxin assay
EIA or PCR based
Prior antibiotic use history
Stool white blood cells and occult blood
Supportive of infectious or ischemic colitis
Nonspecific
Coagulation studies
PT/INR and aPTT
Pre-operative assessment if surgery anticipated
DIC screen in severe disease
Fibrinogen and D-dimer
DIC evaluation with severe sepsis
Mesenteric venous thrombosis evaluation
Blood cultures
If sepsis suspected
Obtain before antibiotics when feasible
Two sets from separate sites
Bacteremia from bacterial translocation
Enteric organisms predominate
Guides antibiotic de-escalation
Special laboratory considerations
Hypercoagulability workup
Protein C, protein S, antithrombin III
Consider in younger patients (<50 years)
Recurrent IC without clear etiology
Antiphospholipid antibodies
Factor V Leiden and prothrombin gene mutation
Defer to outpatient if acute phase
Cardiac biomarkers
Troponin if cardiac ischemia suspected as precipitant
Atrial fibrillation with rapid ventricular response
CHF exacerbation evaluation
BNP or NT-proBNP
Heart failure as precipitant of low-flow state
Guides fluid management
Diagnostic Tests
Scoring Systems
ACG severity classification
Mild disease criteria
Hemodynamically stable
Less than 3 of 6 severity markers
Moderate disease criteria
Hemodynamically stable but 3 or more severity markers
Severity markers: isolated right colon ischemia, WBC >15 times 10 to the 9 per L, hemoglobin <120 mmol/mol, sodium <136 mmol/L, BUN >7.1 mmol/L, LDH >350 U/L
Severe disease criteria
Any peritoneal signs or hemodynamic instability
Pneumatosis or portal venous gas on CT
Predictors of adverse outcome
Right-sided colonic involvement
48.4% adverse outcome rate versus 12.1% for left-sided
Greater than 50% require surgery
Pancolonic involvement
Mortality rate approximately 21%
ICU admission required
Peritoneal signs at presentation
Emergent surgery required
High mortality without prompt intervention
Scoring Systems additional tools
Clinical prediction of severity
Sun et al. systematic review of 2823 patients from 22 studies
Peritoneal signs, hypoalbuminemia, and chronic kidney disease as predictors of surgery
Isolated right colon ischemia as strongest predictor of poor outcome
An J et al. Assessing the Association Between Drug Use and Ischaemic Colitis
BMJ Open 2025
PMID 40398943
Bielefeldt K. Ischemic Colitis as Complication of Medication Use
Digestive Diseases and Sciences 2016
PMID 27073073
Alosetron and tegaserod have highest reported odds ratios for drug-induced IC
Differential diagnosis review
Gecse KB, Vermeire S. Differential Diagnosis of Inflammatory Bowel Disease
Lancet Gastroenterology and Hepatology 2018
PMID 30102183
Yamada's Atlas of Gastroenterology Chapter on Intestinal Ischemia and Vasculitides
Malagelada JR, Malagelada C 2022
Comprehensive review of ischemic conditions
Risk factor epidemiology
Cubiella Fernandez J et al. Risk Factors Associated with Development of Ischemic Colitis
World Journal of Gastroenterology 2010
PMID 20857527
Peripheral arterial disease OR 4.1, diabetes mellitus OR 1.76, dyslipidemia OR 2.12
Calderwood AH, Shaukat A. Colorectal Cancer and Other Colon Conditions in the Older Adult
American Journal of Gastroenterology 2025
doi 10.14309/ajg.0000000000003641.02
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.